97 related articles for article (PubMed ID: 3676728)
21. Effects of protein-modifying reagents on brain tryptamine binding sites: possible involvement of a thiol group in temperature-induced high-affinity [3H]tryptamine binding sites.
Serikyaku S; Saito M; Ishitani R
Jpn J Pharmacol; 1990 Jan; 52(1):51-7. PubMed ID: 1968519
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
Hulihan-Giblin BA; Park YD; Aulakh CS
Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356
[TBL] [Abstract][Full Text] [Related]
23. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
24. Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.
Gutkind JS; Enero MA
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):189-92. PubMed ID: 6493360
[TBL] [Abstract][Full Text] [Related]
25. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
26. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
Waldmeier PC; Stöcklin K
Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007
[TBL] [Abstract][Full Text] [Related]
27. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
Zsilla G; Földi P; Held G; Székely AM; Knoll J
Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
[TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of [3H]tryptamine binding sites from rat brain.
Brüning G; Rommelspacher H
Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722
[TBL] [Abstract][Full Text] [Related]
29. Serotonin binding in mouse brains. Some methodological aspects.
Marcusson J; Oreland L; Winblad B
J Neural Transm; 1983; 56(4):251-63. PubMed ID: 6308144
[TBL] [Abstract][Full Text] [Related]
30. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
Wagner HR; Reches A; Yablonskaya E; Fahn S
Adv Neurol; 1986; 43():645-51. PubMed ID: 2418653
[TBL] [Abstract][Full Text] [Related]
31. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
32. Functional evidence that chronic drugs induce adaptive changes of central autoreceptors regulating serotonin release.
Maura G; Raiteri M
Eur J Pharmacol; 1984 Jan; 97(3-4):309-13. PubMed ID: 6705828
[TBL] [Abstract][Full Text] [Related]
33. Tryptamine receptors: neurochemical and electrophysiological evidence for postsynaptic and functional binding sites.
van Nguyen T; Paterson IA; Juorio AV; Greenshaw AJ; Boulton AA
Brain Res; 1989 Jan; 476(1):85-93. PubMed ID: 2563335
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
[TBL] [Abstract][Full Text] [Related]
35. Temperature-sensitive high affinity [3H]tryptamine binding sites in rat brain.
Karasawa A; Serikyaku S; Ishitani R
Life Sci; 1986 Apr; 38(14):1331-7. PubMed ID: 3083170
[TBL] [Abstract][Full Text] [Related]
36. Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine.
De Deurwaerdère P; Binda C; Corne R; Leone C; Valeri A; Valoti M; Ramsay RR; Fall Y; Marco-Contelles J
ACS Chem Neurosci; 2017 May; 8(5):1026-1035. PubMed ID: 27977122
[TBL] [Abstract][Full Text] [Related]
37. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.
Whitaker-Azmitia PM; Zhang X; Clarke C
Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864
[TBL] [Abstract][Full Text] [Related]
38. Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation.
Aulakh CS; Cohen RM; McLellan C; Murphy DL
Br J Pharmacol; 1983 Sep; 80(1):10-2. PubMed ID: 6317126
[TBL] [Abstract][Full Text] [Related]
39. The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile.
Mousseau DD; Butterworth RF
J Neurochem; 1994 Sep; 63(3):1052-9. PubMed ID: 8051546
[TBL] [Abstract][Full Text] [Related]
40. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
Severina IS
Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
